Particle News: Latest National Institute for Health and Care Excellence news

7 ARTICLES

3mo ago

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

INAVO120 final data show the regimen doubled the time before disease progression compared with standard therapy.

3 ARTICLES

last mo.

Coroner Blames Unattended Delivery for Newborn’s Death and Orders National Review

6 ARTICLES

4mo ago

Study Finds Fewer than Half of Womb Cancer Patients Complete Lynch Syndrome Blood Tests

4 ARTICLES

7mo ago

GPs to Screen Patients for Gambling Habits Under New NHS Guidelines

10 ARTICLES

last mo.

Researchers Propose Widening Preventive Mastectomy Access to Avert 6,500 UK Breast Cancer Cases a Year

9 ARTICLES

2mo ago

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

6 ARTICLES

last mo.

NICE Approves Alyftrek, Extending Modulator Treatment to 95% of Cystic Fibrosis Patients

7 ARTICLES

2mo ago

Lea Hughes Turns to Private Funding for Unapproved Breast Cancer Drug

3 ARTICLES

5mo ago

Nice Proposes Annual Weight Monitoring for Millions with Long-Term Health Conditions

8 ARTICLES

2mo ago

NICE Bars New Alzheimer’s Antibodies from NHS Over Cost and Capacity

10 ARTICLES

3d ago

Pilot RCT Signals Faster IVF Conception for Women 35–42 Using PGT-A

7 ARTICLES

last mo.

NICE Approves First Under-the-Tongue Birch Pollen Immunotherapy Tablet for Severe Hay Fever

4 ARTICLES

2w ago

MHRA Licenses Teplizumab to Delay Onset of Type 1 Diabetes

3 ARTICLES

2mo ago

Campaign for NHS Funding of NET Radiation Therapy Surpasses 46,000 Signatures

6 ARTICLES

3w ago

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Particle.news

National Institute for Health and Care Excellence

Non-departmental public body

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

Coroner Blames Unattended Delivery for Newborn’s Death and Orders National Review

NICE Approves Capivasertib for NHS Use in Advanced Breast Cancer Treatment

BMJ Experts Warn Against Commercial Menopause Testing and Compounded Hormones

Katie Price’s Son Harvey to Begin Mounjaro Treatment Ahead of Southampton Move

UK Regulator Approves First Non-Hormonal Pill for Menopausal Hot Flushes

NHS Adds Linzagolix as New At-Home Endometriosis Treatment

Study Finds Fewer than Half of Womb Cancer Patients Complete Lynch Syndrome Blood Tests

GPs to Screen Patients for Gambling Habits Under New NHS Guidelines

Researchers Propose Widening Preventive Mastectomy Access to Avert 6,500 UK Breast Cancer Cases a Year

Never miss stories about

National Institute for Health and Care Excellence

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

NICE Approves Alyftrek, Extending Modulator Treatment to 95% of Cystic Fibrosis Patients

Lea Hughes Turns to Private Funding for Unapproved Breast Cancer Drug

Nice Proposes Annual Weight Monitoring for Millions with Long-Term Health Conditions

NICE Bars New Alzheimer’s Antibodies from NHS Over Cost and Capacity

Pilot RCT Signals Faster IVF Conception for Women 35–42 Using PGT-A

NICE Approves First Under-the-Tongue Birch Pollen Immunotherapy Tablet for Severe Hay Fever

MHRA Licenses Teplizumab to Delay Onset of Type 1 Diabetes

Campaign for NHS Funding of NET Radiation Therapy Surpasses 46,000 Signatures

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Never miss stories about

National Institute for Health and Care Excellence